Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

Bullboard Posts

Comment by NgamiaSwedeon Mar 01, 2016 11:39pm

170 Views

Post# 24611518

RE:My friend in Sweden mailed to Roger

Thanks vestor 111

Nice to see, I guess we are a few investors from Seweden here now
SpectraCure can be the reason why investors from Sweden find Theralase. I have had some contact with the CEO at Spectracure to get to know a little more and I guess it works both ways.

Regulators is what Roger is dealing with. There is no way he can say, result in a day or to. Because the trial say follow up. Regulators is not all that matters when you are a public company, if they cure 3 people from cancer and people knows about it you will have to tell the market that. And can someone please tell me how they could keep that a secret.
Maybe they do the trial on the moon or something
GLTA

Bullboard Posts

Advancing flagship Ishkõday Gold Project in Ontario